NexMed Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NexMed's estimated annual revenue is currently $11.8M per year.(i)
  • NexMed's estimated revenue per employee is $155,000

Employee Data

  • NexMed has 76 Employees.(i)
  • NexMed grew their employee count by 4% last year.

NexMed's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is NexMed?

NexMed, USA is a wholly owned subsidiary of Apricus Biosciences (NASDAQ:APRI). The Company has a proprietary drug delivery technology, NexACT, which has been used to develop an impressive drug product pipeline, ranging from the pre-clinical stage to the NDA stage.

keywords:N/A

N/A

Total Funding

76

Number of Employees

$11.8M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20.5M76-1%N/A
#2
$18.5M76-11%N/A
#3
$15.6M761%N/A
#4
$20.5M76-1%N/A
#5
$7.8M7621%N/A